Community lists
Sélection · Santé

Biotech

Par InspectStocksPublished 14 oct. 202619 companies0 follower

Drug developers with approved medicines, built mainly on biologic and genetic science.

Regroupées avec l’aide d’un modèle d’IA et relues par notre rédaction. La ligne sous chaque entreprise indique pourquoi elle figure ici.

Sign in to followSign in to copy
Download image
CartesNiveaux
A
  • GILDGilead Sciences
    169,73 $US+40,9 % 1Y

    Sells medicines for HIV, liver disease and cancer

  • BIIBBiogen
    253,39 $US+56,9 % 1Y

    Develops and sells therapies for neurological diseases

  • NBIXNeurocrine Biosciences
    174,35 $US+18,7 % 1Y

    Develops and sells therapies for neurological and endocrine disorders

  • EXELExelixis
    70,71 $US+62,2 % 1Y

    Develops and sells cancer therapies

  • JAZZJazz Pharmaceuticals
    248,18 $US+81,5 % 1Y

    Develops and sells neuroscience and oncology therapies

  • HALOHalozyme Therapeutics
    101,69 $US+44,0 % 1Y

    Licenses drug delivery technology and sells enzyme-based therapies

  • KRYSKrystal Biotech
    308,82 $US+52,1 % 1Y

    Develops and sells topical gene therapies for rare diseases

  • CORTCorcept Therapeutics
    74,52 $US-4,9 % 1Y

    Develops and sells cortisol-modulating therapies

B
  • VRTXVertex Pharmaceuticals
    547,02 $US+26,0 % 1Y

    Develops and sells cystic fibrosis and other medicines

  • ALNYUn cran plus bas parce que la croissance s’essouffleAlnylam Pharmaceuticals
    159,80 $US-64,7 % 1Y

    Develops and sells RNAi therapeutics

  • BBIOBridgeBio Pharma
    79,53 $US+20,1 % 1Y

    Develops therapies for genetic diseases

  • BMRNBioMarin Pharmaceutical
    58,32 $US+5,4 % 1Y

    Develops and sells therapies for rare genetic diseases

C
  • REGNRegeneron Pharmaceuticals
    959,45 $US+41,5 % 1Y

    Develops and sells antibody therapies for eye, allergy and cancer conditions

  • MRNAModerna
    248,70 $US+831,1 % 1Y

    Develops mRNA vaccines and therapies

  • INSMInsmed
    120,64 $US-37,9 % 1Y

    Develops and sells therapies for rare lung diseases

  • UTHRUn cran plus bas parce que la croissance s’essouffleUnited Therapeutics
    595,58 $US+29,0 % 1Y

    Sells therapies for pulmonary arterial hypertension

  • INCYIncyte
    122,23 $US+12,9 % 1Y

    Develops and sells oncology and inflammation therapies

D
  • ASNDAscendis Pharma A/S
    259,10 $US+30,1 % 1Y

    Develops and sells endocrinology rare disease therapies

F
  • BNTXBioNTech
    87,64 $US-21,5 % 1Y

    Develops mRNA vaccines and cancer therapies

DiscussionNo comments yet

Sign in to join the discussion

Be civil and stick to the companies. Comments are opinions, not advice.

    Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.